UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx) – Global Biodefense
University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health (NIH), totaling nearly $33 million over four years. The purpose of the RADx initiative is to speed innovation in the development, commercialization and implementation of technologies for COVID-19 testing. There are several programs within the RADx initiative, including the RADx Underserved Populations (RADx-UP) program, which funds projects aimed at understanding why some communities are disproportionately affected by COVID-19 and reducing the factors as...